News

I-131 Capsule and Solution Production Update June 27th, 2019 Dear Valued Customer, We have been informed by our supplier that the last shipment of Sodium Iodide I-131 products (Therapeutics and Diagnostics) to the Canadian market will be June 26th and...

Iodine-131 Diagnostic and Therapeutic capsule production June 7th, 2019 Dear customers, We would like to inform you that we received information from our vendor of I-131 that their supplier will be in maintenance for a period of 2 weeks starting June...

Special invitation, Monday, June 24, 2019 As part of the SNMMI annual conference to be held from June 22 to June 25, ISOLOGIC invites you to a seminar dedicated to innovative radiopharmaceutical services and the production of PET imaging agents....

MONTREAL, January 10th, 2019   Dear customers, We would like to inform you of our I-131 Dx capsule supply. We will have 100 μCi diagnostic capsules available on January 21st. These capsules will have a calibration date of January 23rd. We also have...

MONTREAL, DECEMBER 20, 2018 Dear customers, We would like to inform you that due to an unforeseeable I-131 Dx capsule production issue we will not be able to produce and ship I-131 Dx capsule for an undetermined period of time. We have a limited...

ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ACQUIRES LANTHEUS MEDICAL IMAGING CANADIAN RADIOPHARMACEUTICAL CENTRES ISOLOGIC is pleased to announce the completion of an asset purchase agreement for the acquisition of the Canadian radiopharmacy and Gludef...

Recently, there has been several public announcements in print and on Canadian television & radio regarding an upcoming shortage in the supply of medical isotopes. In these reactionary articles, while based on the closure of Canada’s NRU reactor,...

GREATER TORONTO AREA BETTER EQUIPPED TO PRODUCE RADIOPHARMACEUTICAL COMPONENTS USED IN CANCER, CARDIAC AND ALZHEIMER’S DETECTION A new cyclotron and radiopharmaceutical manufacturing facility, opened by ISOLOGIC Innovative Radiopharmaceuticals Ltd....